Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes.
Sharma A, Mariam A, Zacherle E, Milinovich A, Bauman J, Sugano DS, Noone J, Rajpura JR, Zimmerman RS, Burguera B, Kattan MW, Misra-Hebert AD, Pantalone KM, Rotroff DM. Sharma A, et al. Among authors: noone j. Diabetes Obes Metab. 2024 Nov;26(11):5347-5357. doi: 10.1111/dom.15896. Epub 2024 Aug 27. Diabetes Obes Metab. 2024. PMID: 39192531
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial.
Blood AJ, Chang LS, Hassan S, Chasse J, Stern G, Gabovitch D, Zelle D, Colling C, Aronson SJ, Figueroa C, Collins E, Ruggiero R, Zacherle E, Noone J, Robar C, Plutzky J, Gaziano TA, Cannon CP, Wexler DJ, Scirica BM. Blood AJ, et al. Among authors: noone j. Circulation. 2024 Jun 4;149(23):1802-1811. doi: 10.1161/CIRCULATIONAHA.124.069494. Epub 2024 Apr 7. Circulation. 2024. PMID: 38583146 Clinical Trial.
Type 2 Diabetes Disease and Management Patterns Across a Large, Diverse Healthcare System: Issues and Opportunities for Guideline-Directed Therapies.
Blood AJ, Chang LS, Colling C, Stern G, Gabovitch D, Zelle D, Zacherle E, Noone J, Robar C, Aronson SJ, Gaziano TA, Matta LS, Plutzky J, Cannon CP, Wexler DJ, Scirica BM. Blood AJ, et al. Among authors: noone j. Am Heart J. 2025 Jan 6:S0002-8703(25)00003-1. doi: 10.1016/j.ahj.2025.01.003. Online ahead of print. Am Heart J. 2025. PMID: 39778759
Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes.
Frazer M, Swift C, Sargent A, Leszko M, Buysman E, Gronroos NN, Alvarez S, Dunn TJ, Noone J, Gamble CL. Frazer M, et al. Among authors: noone j. J Diabetes Metab Disord. 2023 Nov 27;23(1):727-737. doi: 10.1007/s40200-023-01341-y. eCollection 2024 Jun. J Diabetes Metab Disord. 2023. PMID: 38932879 Free PMC article.
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney risk.
Blood AJ, Chang LS, Colling C, Stern G, Gabovitch D, Feldman G, Adan A, Waterman F, Durden E, Hamersky C, Noone J, Aronson SJ, Liberatore P, Gaziano TA, Matta LS, Plutzky J, Cannon CP, Wexler DJ, Scirica BM. Blood AJ, et al. Among authors: noone j. Prim Care Diabetes. 2024 Apr;18(2):202-209. doi: 10.1016/j.pcd.2024.01.005. Epub 2024 Feb 1. Prim Care Diabetes. 2024. PMID: 38302335 Free article. Clinical Trial.
146 results